Astera Labs, Inc. (ALAB)
NASDAQ: ALAB · Real-Time Price · USD
168.83
-3.79 (-2.20%)
At close: Dec 23, 2025, 4:00 PM EST
168.66
-0.17 (-0.10%)
After-hours: Dec 23, 2025, 6:06 PM EST
Astera Labs Stock Forecast
Stock Price Forecast
The 17 analysts that cover Astera Labs stock have a consensus rating of "Strong Buy" and an average price target of $180.41, which forecasts a 6.86% increase in the stock price over the next year. The lowest target is $82 and the highest is $275.
Price Target: $180.41 (+6.86%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astera Labs stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 8 | 8 | 8 |
| Buy | 7 | 7 | 7 | 6 | 7 | 7 |
| Hold | 1 | 1 | 1 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 16 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Northland Capital Markets | Northland Capital Markets | Buy Maintains $175 → $195 | Buy | Maintains | $175 → $195 | +15.50% | Dec 9, 2025 |
| BNP Paribas Exane | BNP Paribas Exane | Buy Initiates $225 | Buy | Initiates | $225 | +33.27% | Nov 20, 2025 |
| Northland Capital Markets | Northland Capital Markets | Hold → Buy Upgrades $175 | Hold → Buy | Upgrades | $175 | +3.65% | Nov 17, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $180 → $215 | Buy | Maintains | $180 → $215 | +27.35% | Nov 5, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $225 → $170 | Hold | Maintains | $225 → $170 | +0.69% | Nov 5, 2025 |
Financial Forecast
Revenue This Year
847.85M
from 396.29M
Increased by 113.95%
Revenue Next Year
1.23B
from 847.85M
Increased by 44.60%
EPS This Year
1.81
from -0.64
EPS Next Year
2.40
from 1.81
Increased by 32.43%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 874.1M | 1.7B | ||||
| Avg | 847.9M | 1.2B | ||||
| Low | 811.7M | 1.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 120.6% | 103.7% | ||||
| Avg | 113.9% | 44.6% | ||||
| Low | 104.8% | 23.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.87 | 2.96 | |||
| Avg | 1.81 | 2.40 | |||
| Low | 1.72 | 1.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 63.2% | |||
| Avg | - | 32.4% | |||
| Low | - | 8.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.